Citations

Showing 10 of 108081 citations.

REM S leep B ehavior D isorder in P arkin
Louis, Erik K. St. , Boeve, Angelica, St Louis, Erik K, Boeve, Angelica R, Boeve, Bradley F. , St Louis, E K

Mayo Clinic

Movement Disorders | May 17, 2017 | Volume: 32 | Issue: 5 | Pages: 645-658

10.1002/mds.27018 | PMID 28513079 Get It

ABSTRACT Rapid eye movement sleep behavior disorder is characterized by dream enactment and complex motor behaviors during rapid eye movement sleep and rapid eye movement sleep atonia loss (rapid eye movement sleep without atonia) during polysomnography. Rapid eye movement sleep behavior disorder may be idiopathic or symptomatic and in both settings is highly associated with synucleinopathy neurodegeneration, especially Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure. Rapid eye movement sleep behavior disorder frequently manifests years to decades prior to overt motor, cognitive, or autonomic impairments as the presenting manifestation of synucleinopathy, along with other subtler prodromal “soft” signs of hyposmia, constipation, and orthostatic hypotension. Between 35% and 91.9% of patients initially diagnosed with idiopathic rapid eye movement sleep behavior disorder at a sleep center later develop a defined neurodegenerative disease. Less is known about the long‐term prognosis of community‐dwelling younger patients, especially women, and rapid eye movement sleep behavior disorder associated with antidepressant medications. Patients with rapid eye movement sleep behavior disorder are frequently prone to sleep‐related injuries and should be treated to prevent injury with either melatonin 3‐12 mg or clonazepam 0.5‐2.0 mg to limit injury potential. Further evidence‐based studies about rapid eye movement sleep behavior disorder are greatly needed, both to enable accurate prognostic prediction of end synucleinopathy phenotypes for individual patients and to support the application of symptomatic and neuroprotective therapies. Rapid eye movement sleep behavior disorder as a prodromal synucleinopathy represents a defined time point at which neuroprotective therapies could potentially be applied for the prevention of Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure. © 2017 International Parkinson and Movement Disorder Society
The Renal–Cardiac Connection in Subjects with Preserved Ejection Fraction: A Population Based Study
Jain, Amit Kumar C , Chen, Horng H. , Scott, Christopher G.

Mayo Clinic

ESC Heart Failure | May 17, 2017 | Volume: 4 | Issue: 3 | Pages: 266-273

10.1002/ehf2.12143 | PMID 28772030 Get It

Abstract Aims Chronic kidney disease (CKD) is prevalent and is associated with increased cardiovascular morbidity and mortality. The interaction between diastolic dysfunction (DD) and CKD in subjects with preserved systolic function is not well defined. This study sought to determine the association between renal function and DD in subjects with preserved ejection fraction. Methods and results Through the Rochester Epidemiology Project, subjects who underwent echocardiography over 2 years with EF ≥50% were identified and the clinical data were obtained. Glomerular filtration rate (GFR) was estimated using the modification of diet in renal disease equation. Linear regression was used to test for association of GFR and DD. DD was defined as follows: Grade 2 or pseudonormal pattern (0.75 < E/A ≤ 1.5, E/e′ ≥ 10, DT > 140 ms, ΔE/A ≥ 0.5, and PV S < D) or Grade 3+ or restrictive pattern (E/A > 1.5, E/e′ ≥ 10, DT < 140 ms, and PV S < D). Cox regression was used to assess correlation of GFR and DD with time-to-event outcomes. A total of 2056 patients were identified. There was significant correlation between worsening GFR and degree of DD assessed by echo Doppler E/e′ ratio (P = 0.005), left ventricular mass index (P = 0.004), and right ventricular systolic pressure (P = 0.01). Worsening GFR was associated with increased mortality, development of heart failure, and hospitalization (P < 0.001). Within each GFR group, abnormal DD was associated with a higher risk of the clinical outcomes. No interaction between GFR and DD was noted, suggesting an increased risk of events associated with abnormal DD across ranges of GFR. Conclusions Worsening GFR was associated with a greater degree of diastolic dysfunction and adverse clinical outcomes. Within each GFR group, the presence of DD was associated with increased morbidity and mortality. Further studies are warranted to determine if improving DD in patients with CKD will benefit clinical outcomes.
Negative Cardiovascular Consequences of Small Molecule Immunosuppressants
Chakkera, Harini A. , Sharif, Adnan , Kaplan, Bruce , Chakkera, Harini A

Mayo Clinic

Clinical Pharmacology & Therapeutics | May 16, 2017 | Volume: 102 | Issue: 2 | Pages: 269-276

10.1002/cpt.738 | PMID 28512771 Get It

Immunosuppressants are critical after transplantation and prescribed as immune‐modulators for autoimmune disorders and glomerulonephritides. Immunosuppressants include large (e.g., thymoglobulin, alemtuzumab, and rituximab) and small molecules (e.g., corticosteroids, calcineurin inhibitors, antimetabolites, and mammalian target of rapamycin (mTOR) inhibitors). The majority of the small molecules worsen traditional cardiovascular risks. This review describes cardiovascular risks of small molecule immunosuppressants: corticosteroids, calcineurin inhibitors (tacrolimus and cyclosporine), and mTOR inhibitors (rapamycin), by categorizing these risks into two categories: ischemic heart disease and nonischemic cardiac effects.
Antithrombotic Therapy for Venous Thromboembolic Disease
Jain, Atul , Cifu, Adam S.

Mayo Clinic

JAMA | May 16, 2017 | Volume: 317 | Issue: 19 | Pages: 2008

10.1001/jama.2017.1928 | PMID 28510665 Get It

A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the Americ
group:, Writing, Glaudemans, Andor W.J.M. , Lancellotti, Patrizio , Hyafil, Fabien , Blankstein, Ron, Schwartz, Ronald G. , Russell, Raymond R., Gimelli, Alessia , Rouzet, François , Hacker, Marcus , Plein, Sven , group:, Document reading, Sciagrà, Roberto , Bucerius, Jan , Verberne, Hein J. , Lindner, Oliver , Übleis, Christopher, Agostini, Denis, Signore, Alberto , Edvardsen, Thor , Neglia, Danilo , Beanlands, Rob , Carli, Marcelo F. Di , Dilsizian, Vasken , Habib, Gilbert, Delgado, Victoria , Cosyns, Bernard, Flachskampf, Frank A. , Gerber, Bernhard , Haugaa, Kristina H. , Lombardi, Massimo, Slart, Riemer H. J. A. , Blankstein, Ron , Jaber, Wael A. , Gheysens, Olivier S. , Miller, Edward J. , Dorbala, Sharmila , Donal, Erwan , Chareonthaitawee, Panithaya , Soman, Prem , Habib, G., Cardim, Nuno Miguel , Masci, Pier Giorgio , Delgado, Victoria , Plein, Sven , Haugaa, Kristina , Neglia, Danilo

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | May 16, 2017 | Volume: 18 | Issue: 10 | Pages: 1073-1089

10.1093/ehjci/jex146 | PMID 28984894 Get It

Abstract This joint position paper illustrates the role and the correct use of echocardiography, radionuclide imaging with 18F-fluorodeoxyglucose positron emission tomography, radionuclide myocardial perfusion imaging and cardiovascular magnetic resonance imaging for the evaluation and management of patients with known or suspected cardiac sarcoidosis. This position paper will aid in standardizing imaging for cardiac sarcoidosis and may facilitate clinical trials and pooling of multi-centre data on cardiac sarcoidosis. Proposed flow charts for the work up and management of cardiac sarcoidosis are included.
A Decision Tree for Nonmetric Sex Assessment from the Skull
Langley, Natalie R. , Dudzik, Beatrix , Cloutier, Alesia

Mayo Clinic

Journal of Forensic Sciences | May 16, 2017 | Volume: 63 | Issue: 1 | Pages: 31-37

10.1111/1556-4029.13534 | PMID 28508544 Get It

Abstract This study uses five well‐documented cranial nonmetric traits (glabella, mastoid process, mental eminence, supraorbital margin, and nuchal crest) and one additional trait (zygomatic extension) to develop a validated decision tree for sex assessment. The decision tree was built and cross‐validated on a sample of 293 U.S. White individuals from the William M. Bass Donated Skeletal Collection. Ordinal scores from the six traits were analyzed using the partition modeling option in JMP Pro 12. A holdout sample of 50 skulls was used to test the model. The most accurate decision tree includes three variables: glabella, zygomatic extension, and mastoid process. This decision tree yielded 93.5% accuracy on the training sample, 94% on the cross‐validated sample, and 96% on a holdout validation sample. Linear weighted kappa statistics indicate acceptable agreement among observers for these variables. Mental eminence should be avoided, and definitions and figures should be referenced carefully to score nonmetric traits.
Melanoma Masquerading as a Zosteriform Rash
Ibrahim, Saif , Al-Turk, Bashar, Harris, Ciel , Al-Saffar, Farrah , Said, Sayf, Farsi, Maheera, Winder, Jeffrey, Landa, Christian, Winder, Jeffrey, Landa, Christian Michel Kouala

Mayo Clinic

American Journal of Case Reports | May 16, 2017 | Volume: 18 | Issue: No issue available | Pages: 537-540

10.12659/ajcr.902377 | PMID 28507284 Get It

Early activation of deleterious molecular pathways in the kidney in experimental heart failure with atrial remodeling
Ichiki, Tomoko , Huntley, Brenda K., Harty, Gail J., Sangaralingham, S. Jeson , Burnett, John C. , Sangaralingham, S. Jeson

Mayo Clinic

Physiological Reports | May 16, 2017 | Volume: 5 | Issue: 9 | Pages: e13283

10.14814/phy2.13283 | PMID 28507167 Get It

Teaching Neuro Images : Prominent spinal cord atrophy and white matter changes in adult polyglucosan body disease
López‐Chiriboga, A. Sebastian , Dichgans, Martin , Dichgans, Martin

Mayo Clinic

Neurology | May 15, 2017 | Volume: 88 | Issue: 20 | Pages: No page available

10.1212/wnl.0000000000003945 | PMID 28507268 Get It